Legislation to Establish Mandatory Registry for Clinical Trials for Drugs and Biologics
Read the Bill:
http://www.house.gov/markey/Issues/iss_health_bill040909.pdf
International Committee of Medical Journal Editors
“International Committee of Medical Journal Editors (ICMJE) proposes comprehensive trials registration as a solution to the problem of selective awareness and announces that all eleven ICMJE member journals will adopt a trials-registration policy to promote this goal.” Read the Statement from the International Committee of Medical Journal Editors in NEJM:
http://content.nejm.org/cgi/content/full/NEJMe048225
US Congressional Subcommittee Holds Hearing on Clinical Trial Disclosure Rules
At a day-long hearing in Washington, DC on September 9, the House Energy and Commerce Subcommittee on Oversight and Investigations repeatedly took both Food and Drug Administration (FDA) and pharmaceutical company officials to task for failing to fully disclose clinical trial results.
[The Scientist, Sept. 10, 2004: http://www.biomedcentral.com/news/20040910/04/]
